Dose-related effects of lauric acid on antropyloroduodenal motility, gastrointestinal hormone release, appetite, and energy intake in healthy men

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 289, Issue 4 58-4, 2005, Pages

  Little, Tanya J ^a   Feltrin, Kate L ^a   Horowitz, Michael ^a   Smout, Andre J P M ^b   Rades, Thomas ^c   Meyer, James H ^a   Pilichiewicz, Amelia N ^a   Wishart, Judith ^a   Feinle Bisset, Christine ^a,d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Cholecystokinin; Free fatty acid; Glucagon like peptide 1; Pyloric motility

Indexed keywords

CHOLECYSTOKININ; DECANOIC ACID; GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE 1; LAURIC ACID;

ADULT; APPETITE; ARTICLE; CALORIC INTAKE; CHOLECYSTOKININ BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DUODENUM MOTILITY; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; INFUSION; MALE; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; PYLORUS; RANDOMIZED CONTROLLED TRIAL; STOMACH ANTRUM;

ADULT; APPETITE; CHOLECYSTOKININ; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DUODENUM; ENERGY INTAKE; ENTERAL NUTRITION; GASTROINTESTINAL HORMONES; GASTROINTESTINAL MOTILITY; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; HUMANS; LAURIC ACIDS; MALE; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; PYLORIC ANTRUM; PYLORUS;

EID: 25844521136     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00290.2005     Document Type: Article

References (37)

1. Ament ME, Shimoda SS, Saunders DR, and Rubin CE. Pathogenesis of steatorrhea in three cases of small intestinal stasis syndrome. Gastroenterolagy 63: 728-747, 1972.
2. Bland JM and Altman DG. Calculating correlation coefficients with repeated observations: part 1 - correlation within subjects. BMJ 310: 446, 1995.
3. Borgstrom B, Dahlqvist A, Lundh G, and Sjovall J. Studies of intestinal digestion and absorption in the human. J Clin Invest 36: 1521-1536, 1957.
4. Borovicka J, Schwizer W, Guttmann G, Hartmann D, Kosinski M, Wastiel C, Bischof-Delaloye A, and Fried M. Role of lipase in the regulation of postprandial gastric acid secretion and emptying of fat in humans: a study with orlistat, a highly specific lipase inhibitor. Gut 46: 774-781, 2000.
5. Camilleri M and Malagelada JR. Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest 14: 420-427, 1984.
6. Chapman IM, Goble EA, Wittert GA, and Horowitz M. Effects of small-intestinal fat and carbohydrate infusions on appetite and food intake in obese and nonobese men. Am J Clin Nutr 69: 6-12, 1999.
7. Cook CG, Andrews JM, Jones KL, Wittert GA, Chapman IM, Morley JE, and Horowitz M. Effects of small intestinal nutrient infusion on appetite and pyloric motility are modified by age. Am J Physiol Regul Integr Comp Physiol 273: R755-R761, 1997.
8. Cox JE, Kelm GR, Meller ST, and Randich A. Suppression of food intake by GI fatty acid infusions: roles of celiac vagal afferents and cholecystokinin. Physiol Behav 82: 27-33, 2004.
9. Eissele R, Goke R, Willemer S, Harthus HP, Vermeer H, Arnold R, and Goke B. Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest 22: 283-291, 1992.
10. Feinle C, O'Donovan DG, Doran S, Andrews JM, Wishart J, Chapman I, and Horowitz M. Effects of fat digestion on appetite, APD motility, and gut hormones in response to duodenal fat infusion in humans. Am J Physiol Gastrointest Liver Physiol 284: G798-G807, 2003.
11. Feinle C, Rades T, Otto B, and Fried M. Fat digestion modulates gastrointestinal sensations induced by gastric distention and duodenal lipid in humans. Gastroenterology 120: 1100-1107, 2001.
12. Feltrin KL, Little TJ, Meyer JH, Horowitz M, Smout AJ, Wishart J, Pilichiewicz AN, Rades T, Chapman IM, and Feinle-Bisset C. Effects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length. Am J Physiol Regul Integr Comp Physiol 287: R524-R533, 2004.
13. Flint A, Raben A, Astrup A, and Hoist JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 101: 515-520, 1998.
14. Heddle R, Collins PJ, Dent J, Horowitz M, Read NW, Chatterton B, and Houghton LA. Motor mechanisms associated with slowing of the gastric emptying of a solid meal by an intraduodenal lipid infusion. J Gastroenterol Hepatol 4: 437-447, 1989.
15. Heddle R, Dent J, Toouli J, and Read NW. Topography and measurement of pyloric pressure waves and tone in humans. Am J Physiol Gastrointest Liver Physiol 255: G490-G497, 1988.
16. Hunt JN and Knox MT. A relation between the chain length of fatty acids and the slowing of gastric emptying. J Physiol 194: 327-336, 1968.
17. Kissileff HR, Pi-Sunyer FX, Thornton J, and Smith GP. C-terminal octapeptide of cholecystokinin decreases food intake in man. Am J Clin Nutr 34: 154-160, 1981.
18. Lal S, Kirkup AJ, Brunsden AM, Thompson DG, and Grundy D. Vagal afferent responses to fatty acids of different chain length in the rat. Am J Physiol Gastrointest Liver Physiol 281: G907-G915, 2001.
19. Lal S, McLaughlin J, Barlow J, D'Amato M, Giacovelli G, Varro A, Dockray GJ, and Thompson DG. Cholecystokinin pathways modulate sensations induced by gastric distension in man. Am J Physiol Gastrointest Liver Physiol 287: G72-G79, 2004.
20. Lin HC, Doty JE, Reedy TJ, and Meyer JH. Inhibition of gastric emptying by sodium oleate depends on length of intestine exposed to nutrient. Am J Physiol Gastrointest Liver Physiol 259: G1031-G1036, 1990.
21. Macintosh CG, Morley JE, Wishart J, Morris H, Jansen JB, Horowitz M, and Chapman IM. Effect of exogenous cholecystokinin (CCK)-8 on food intake and plasma CCK, leptin, and insulin concentrations in older and young adults: evidence for increased CCK activity as a cause of the anorexia of aging. J Clin Endocrinol Metab 86: 5830-5837, 2001.
22. Matzinger D, Degen L, Drewe J, Meuli J, Duebendorfer R, Ruckstuhl N, D'Amato M, Rovati L, and Beglinger C. The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut 46: 688-693, 2000.
23. McLaughlin J, Grazia-Luca M, Jones MN, D'Amato M, Dockray GJ, and Thompson DG. Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology 116: 46-53, 1999.
24. Mensink RP, Zock PL, Kester AD, and Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 77: 1146-1155, 2003.
25. Meyer JH, Hlinka M, Tabrizi Y, DiMaso N, and Raybould HE. Chemical specificities and intestinal distributions of nutrient-driven satiety. Am J Physiol Regul Integr Comp Physiol 275: R1293-R1307, 1998.
26. Meyer JH and Jones RS. Canine pancreatic responses to intestinally perfused fat and products of fat digestion. Am J Physiol 226: 1178-1187, 1974.
27. O'Donovan D, Feinle-Bisset C, Wishart J, and Horowitz M. Lipase inhibition attenuates the acute effects of oral fat on food intake in healthy subjects. Br J Nutr 90: 849-852, 2003.
28. Parker B, Sturm K, MacIntosh CG, Feinle C, Horowitz M, and Chapman IM. Relation between food intake and visual analogue rating scales of appetite and other sensations in healthy older and young subjects. Eur J Clin Nutr 58: 212-218, 2004.
29. Pilichiewicz A, O'Donovan D, Feinle C, Lei Y, Wishart JM, Bryant L, Meyer JH, Horowitz M, and Jones KL. Effect of lipase inhibition on gastric emptying of, and the glycemic and incretin responses to, an oil/aqueous drink in type 2 diabetes mellitus. J Clin Endocrinol Metab 88: 3829-3834, 2003.
30. Porter HP, Saunders DR, Tytgat G, Brunser O, and Rubin CE. Fat absorption in bile fistula man. A morphological and biochemical study. Gastroenterology 60: 1008-1019, 1971.
31. Rehfeld JF. Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog. J Biol Chem 253: 4022-4030, 1978.
32. Samsom M, Roelofs JM, Akkermans LM, van Berge Henegouwen GP, and Smout AJ. Proximal gastric motor activity in response to a liquid meal in type I diabetes mellitus with autonomic neuropathy. Dig Dis Sci 43: 491-496, 1998.
33. Schwizer W, Asal K, Kreiss C, Mettraux C, Borovicka J, Remy B, Guzelhan C, Hartmann D, and Fried M. Role of lipase in the regulation of upper gastrointestinal function in humans. Am J Physiol Gastrointest Liver Physiol 273: G612-G620, 1997.
34. Sepple CP and Read NW. Gastrointestinal correlates of the development of hunger in man. Appetite 13: 183-191, 1989.
35. Stunkard AJ and Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 29: 71-83, 1985.
36. Wishart JM, Horowitz M, Morris HA, Jones KL, and Nauck MA. Relation between gastric emptying of glucose and plasma concentrations of glucagon-like peptide-1. Peptides 19: 1049-1053, 1998.
37. Xu X, Zhu H, and Chen JD. Pyloric electrical stimulation reduces food intake by inhibiting gastric motility in dogs. Gastroenterology 128: 43-50, 2005.